31.19
price down icon0.45%   -0.14
after-market Handel nachbörslich: 31.60 0.41 +1.31%
loading

Xenon Pharmaceuticals Inc Aktie (XENE) Neueste Nachrichten

pulisher
03:42 AM

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Bought by Bank of New York Mellon Corp - Defense World

03:42 AM
pulisher
Jul 22, 2025

How Xenon Pharmaceuticals Inc. stock performs during market volatilityFree Access to Community - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Xenon Pharmaceuticals Inc. Stock Analysis and ForecastFree Bull & Bear Market Updates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Xenon Pharmaceuticals Inc. a good long term investmentFree Stock Selection - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Xenon Pharmaceuticals Inc. stock priceHigh-octane financial growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Xenon Pharmaceuticals Inc. stockRapid profit acceleration - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Mutual of America Capital Management LLC Buys New Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Jul 21, 2025
pulisher
Jul 20, 2025

Should I buy Xenon Pharmaceuticals Inc. stock before earningsFree Smart Money Stock Analysis - Newser

Jul 20, 2025
pulisher
Jul 19, 2025

(XENE) Investment Analysis and Advice - news.stocktradersdaily.com

Jul 19, 2025
pulisher
Jul 16, 2025

Teacher Retirement System of Texas Reduces Stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

Why Xenon Pharmaceuticals Inc. stock attracts strong analyst attentionReliable High Profit Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Xenon Pharmaceuticals Inc. stock price move sharplyHigh Yield Opportunities - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

We're Hopeful That Xenon Pharmaceuticals (NASDAQ:XENE) Will Use Its Cash Wisely - Yahoo Finance

Jul 14, 2025
pulisher
Jul 10, 2025

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Average Recommendation of “Buy” by Brokerages - Defense World

Jul 10, 2025
pulisher
Jul 10, 2025

Traders Buy Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - Defense World

Jul 10, 2025
pulisher
Jul 08, 2025

How to Take Advantage of moves in (XENE) - news.stocktradersdaily.com

Jul 08, 2025
pulisher
Jul 07, 2025

CFO changes at Biocryst, Xenon, Century, Pyxis - biocentury.com

Jul 07, 2025
pulisher
Jul 06, 2025

RBC Raises Xenon Price Target, Cites Phase III Optimism for Epilepsy Drug - MSN

Jul 06, 2025
pulisher
Jul 04, 2025

Xenon Appoints CEO Ian Mortimer as Interim CFO - The Globe and Mail

Jul 04, 2025
pulisher
Jul 03, 2025

XENE CEO Named Interim CFO After Sherry Aulin Resigns | XENE SEC FilingForm 8-K - Stock Titan

Jul 03, 2025
pulisher
Jun 30, 2025

Xenon Pharmaceuticals Inc.(NasdaqGM:XENE) added to Russell Small Cap Comp Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

Xenon Pharmaceuticals: Riding the Russell Wave to Institutional Inflows and Clinical Milestones? - AInvest

Jun 29, 2025
pulisher
Jun 28, 2025

Xenon Joins the Russell 3000® and Russell 2000® Indexes - The Manila Times

Jun 28, 2025
pulisher
Jun 27, 2025

Xenon Pharmaceuticals added to Russell 3000 and 2000 indexes - Investing.com India

Jun 27, 2025
pulisher
Jun 27, 2025

Xenon Pharmaceuticals Inc. Added to Russell 3000® and Russell 2000® Indexes in Annual Reconstitution - Quiver Quantitative

Jun 27, 2025
pulisher
Jun 26, 2025

Xenon Pharmaceuticals Announces Equity Inducement Grants to New Employees - TipRanks

Jun 26, 2025
pulisher
Jun 25, 2025

Is Xenon Pharmaceuticals, Inc. overvalued or undervalued? - MarketsMojo

Jun 25, 2025
pulisher
Jun 24, 2025

Xenon Announces Appointment of Darren Cline as Chief Commercial Officer - The Globe and Mail

Jun 24, 2025
pulisher
Jun 18, 2025

Long Term Trading Analysis for (XENE) - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 15, 2025

Xenon Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:XENE) - MarketBeat

Jun 15, 2025
pulisher
Jun 15, 2025

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Average Recommendation of “Buy” from Analysts - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

RBC Capital Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Raises Target Price to $57 - 富途牛牛

Jun 14, 2025
pulisher
Jun 13, 2025

Xenon Pharmaceuticals price target raised to $57 from $55 at RBC Capital - Investing.com Canada

Jun 13, 2025
pulisher
Jun 13, 2025

RBC Raises Price Target on Xenon Pharmaceuticals to $57 From $55, Keeps Outperform, Speculative Risk - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

Cantor Fitzgerald Estimates XENE FY2026 Earnings - MarketBeat

Jun 13, 2025
pulisher
Jun 12, 2025

Traders Purchase High Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Xenon Pharmaceuticals (XENE) Up 8.7% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Jun 11, 2025
pulisher
Jun 11, 2025

Brokers Set Expectations for XENE FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Xenon Pharmaceuticals at Goldman Sachs Conference: Strategic Clinical Advances By Investing.com - Investing.com Canada

Jun 10, 2025
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Kapitalisierung:     |  Volumen (24h):